HETEROCYCLIC TRIAZOLE COMPOUNDS AS AGONISTS OF THE APJ RECEPTOR
申请人:AMGEN INC.
公开号:US20170320860A1
公开(公告)日:2017-11-09
Compounds of Formula I and Formula II, pharmaceutically acceptable salts thereof, stereoisomers of any of the foregoing, or mixtures thereof are agonists of the APJ Receptor and may have use in treating cardiovascular and other conditions. Compounds of Formula I and Formula II have the following structures:
where the definitions of the variables are provided herein.
Compounds for use in preparing heterocyclic triazole agonists of the APJ receptor
申请人:AMGEN INC.
公开号:US10150760B2
公开(公告)日:2018-12-11
Compounds of Formula V, salts thereof, tautomers thereof, and salts of the tautomers have the following structure and are useful compounds in preparing small molecule agonists of the APJ Receptor:
where the definitions of the variables are provided herein.
式 V 的化合物、其盐、同系物和同系物的盐具有如下结构,是制备 APJ 受体小分子激动剂的有用化合物:
其中变量的定义见本文。
COMPOUNDS FOR USE IN PREPARING HETEROCYCLIC TRIAZOLE AGONISTS OF THE APJ RECEPTOR
申请人:AMGEN INC.
公开号:US20180222895A1
公开(公告)日:2018-08-09
Compounds of Formula V, salts thereof, tautomers thereof, and salts of the tautomers have the following structure and are useful compounds in preparing small molecule agonists of the APJ Receptor:
where the definitions of the variables are provided herein.
US9988369B2
申请人:——
公开号:US9988369B2
公开(公告)日:2018-06-05
Stoermer; Koenig, Chemische Berichte, 1906, vol. 39, p. 496